These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 7591693)
1. Oral hypoglycemic agents as an alternative therapy for gestational diabetes. Hod M; Shafrir E Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693 [No Abstract] [Full Text] [Related]
2. Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus. Langer O Obstet Gynecol Clin North Am; 2007 Jun; 34(2):255-74, ix. PubMed ID: 17572271 [TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of oral hypoglycemic drugs in the metabolic control of patients with gestational diabetes]. Valdés R E; Soto-Chacón E; Lahsen M R; Barrera H C; Candía P P Rev Med Chil; 2008 Jul; 136(7):915-20. PubMed ID: 18949170 [TBL] [Abstract][Full Text] [Related]
4. When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus. Langer O J Matern Fetal Neonatal Med; 2002 Apr; 11(4):218-25. PubMed ID: 12375674 [TBL] [Abstract][Full Text] [Related]
6. Oral agent therapy in the treatment of type 2 diabetes. Feinglos MN; Bethel MA Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564 [No Abstract] [Full Text] [Related]
7. Oral hypoglycemic agents in pregnancy: their time has come. Langer O J Matern Fetal Neonatal Med; 2002 Dec; 12(6):376-83. PubMed ID: 12683647 [TBL] [Abstract][Full Text] [Related]
8. Counterpoint: Oral hypoglyemic agents should be used to treat diabetic pregnant women. Coetzee EJ Diabetes Care; 2007 Nov; 30(11):2980-2. PubMed ID: 17965316 [No Abstract] [Full Text] [Related]
9. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy. Buse JB Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565 [No Abstract] [Full Text] [Related]
10. Beyond sulfonylureas: new oral medications in the treatment of NIDDM (type II DM). Capriotti T Medsurg Nurs; 1997 Jun; 6(3):166-9. PubMed ID: 9238992 [No Abstract] [Full Text] [Related]
12. [Update on new oral treatment for diabetes]. Awad J; Schindel B; Schindel Y Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897 [No Abstract] [Full Text] [Related]
13. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes. Charbonnel B Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387 [No Abstract] [Full Text] [Related]
14. [Oral therapy of type II diabetes]. Haupt E; Schöffling K Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363 [No Abstract] [Full Text] [Related]
15. [40 years of using sulfonylurea derivatives for treatment of diabetes]. Sieradzki J Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529 [TBL] [Abstract][Full Text] [Related]
16. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents]. Pernet A; Bäbler M; Ganz K Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361 [No Abstract] [Full Text] [Related]
17. [Cyclohexamide. A new oral hypoglycemic agent]. Villaseñor A; Parra A; López Amor E; Rull JA; Lozano-Castañeda O Rev Invest Clin; 1967; 19(2):149-57. PubMed ID: 5317602 [No Abstract] [Full Text] [Related]
18. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control. Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153 [No Abstract] [Full Text] [Related]
19. Insulin-dependent diabetes of pregnancy treated with the combination of sulfonylurea and insulin. Ravina A Isr J Med Sci; 1995 Oct; 31(10):623-5. PubMed ID: 7591687 [No Abstract] [Full Text] [Related]
20. Rosiglitazone monotherapy and type 2 diabetes. Lawrence IG Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215 [No Abstract] [Full Text] [Related] [Next] [New Search]